MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Revenue (Quarterly): 23.32M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 23.32M |
| June 30, 2024 | 22.16M |
| March 31, 2024 | 19.83M |
| December 31, 2023 | 19.40M |
| September 30, 2023 | 19.35M |
| June 30, 2023 | 16.74M |
| March 31, 2023 | 14.70M |
| Date | Value |
|---|---|
| December 31, 2022 | 12.89M |
| September 30, 2022 | 11.15M |
| June 30, 2022 | 6.903M |
| March 31, 2022 | 6.106M |
| December 31, 2021 | 6.013M |
| September 30, 2021 | 5.495M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.495M
Minimum
Sep 2021
23.32M
Maximum
Sep 2024
14.16M
Average
14.70M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Galapagos NV | 65.82M |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 1.392M |
| Celyad Oncology SA | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.19M |
| Total Expenses (Quarterly) | 29.41M |
| EPS Diluted (Quarterly) | -0.40 |
| Enterprise Value | 95.14M |
| Gross Profit Margin (Quarterly) | 61.22% |
| Profit Margin (Quarterly) | -47.99% |
| Earnings Yield | -80.85% |
| Normalized Earnings Yield | -80.85 |